ID: ALA603864

Max Phase: Preclinical

Molecular Formula: C21H16N4O2S

Molecular Weight: 388.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1OCc1cn2c(-c3ccc4ccccc4n3)nnc2s1

Standard InChI:  InChI=1S/C21H16N4O2S/c1-26-18-8-4-5-9-19(18)27-13-15-12-25-20(23-24-21(25)28-15)17-11-10-14-6-2-3-7-16(14)22-17/h2-12H,13H2,1H3

Standard InChI Key:  XWNYFASWMJVWLC-UHFFFAOYSA-N

Associated Targets(Human)

Hypoxia-inducible factor 1-alpha inhibitor 79 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 388.45Molecular Weight (Monoisotopic): 388.0994AlogP: 4.59#Rotatable Bonds: 5
Polar Surface Area: 61.54Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.01CX LogP: 3.94CX LogD: 3.94
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.44Np Likeness Score: -1.24

References

1. Ko S, Lee MK, Shin D, Park H..  (2009)  Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.,  17  (22): [PMID:19822432] [10.1016/j.bmc.2009.09.034]

Source